Archive for the ‘Cardium Therapeutics’ Category

Taxus Cardium Pharmaceuticals Group Inc

April 23rd, 2014 | Posted in 2014, Cardium Therapeutics, Taxus Cardium Pharmaceuticals Group

Cardium Therapeutics has changed its name to Taxus Cardium Pharmaceuticals Group Inc in order to reflect its strategic collaboration and funding arrangement with Shangai-based Shanxi Taxus Pharmaceuticals Co. Ltd.

Cardium Therapeutics

October 11th, 2011 | Posted in 2011, Cardium Therapeutics

Cardium Therapeutics – San Diego:  Announced that it has received 510(k) clearance from the FDA to market and sell the company’s new Excellagean Professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds. The company believes that Excellagen provides a new would care option for the marketplace.

Cardium Therapeutics

November 19th, 2010 | Posted in Cardium Therapeutics

Cardium Therapeutics, San Diego, announced a co-development and strategic licensing agreement with BioZone Laboratories Inc. for the formulation, manufacture, and licensing of a portfolio of up to 20 aesthetics, advanced skin care formulations and other products for Cardium’s MedPodium product line. Under the terms of the agreement, a product manufactured for Cardium by BioZone will […]